Jeffrey E. Young, Chief Financial Officer at OvaScience, Inc. (OVAS), bought 3,450 shares at $10.70 ($37K) on 2015-10-05, disclosed to the SEC on 2015-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.